Novo Nordisk A/S (NVO)
40.00
+0.86
(+2.20%)
USD |
NYSE |
Oct 30, 16:00
39.94
-0.06
(-0.15%)
Pre-Market: 20:00
Novo Nordisk 30-Day Average Daily Volume : 13.38M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 13.38M |
| October 29, 2026 | 13.22M |
| October 28, 2026 | 13.30M |
| October 27, 2026 | 13.31M |
| October 26, 2026 | 13.38M |
| October 23, 2026 | 13.33M |
| October 22, 2026 | 13.39M |
| October 21, 2026 | 13.33M |
| October 20, 2026 | 13.40M |
| October 19, 2026 | 13.43M |
| October 16, 2026 | 13.39M |
| October 15, 2026 | 13.32M |
| October 14, 2026 | 13.28M |
| October 13, 2026 | 13.28M |
| October 12, 2026 | 13.22M |
| October 09, 2026 | 13.22M |
| October 08, 2026 | 13.33M |
| October 07, 2026 | 13.23M |
| October 06, 2026 | 13.29M |
| October 05, 2026 | 13.16M |
| October 02, 2026 | 12.90M |
| October 01, 2026 | 12.88M |
| September 30, 2026 | 13.11M |
| September 29, 2026 | 12.79M |
| September 28, 2026 | 12.97M |
| Date | Value |
|---|---|
| September 25, 2026 | 12.95M |
| September 24, 2026 | 12.95M |
| September 23, 2026 | 12.60M |
| September 22, 2026 | 12.25M |
| September 21, 2026 | 11.77M |
| September 18, 2026 | 10.53M |
| September 17, 2026 | 10.62M |
| September 16, 2026 | 10.93M |
| September 15, 2026 | 12.13M |
| September 14, 2026 | 12.23M |
| September 11, 2026 | 12.90M |
| September 10, 2026 | 12.89M |
| September 09, 2026 | 12.96M |
| September 08, 2026 | 12.98M |
| September 04, 2026 | 12.86M |
| September 03, 2026 | 13.01M |
| September 02, 2026 | 12.99M |
| September 01, 2026 | 12.82M |
| August 31, 2026 | 12.70M |
| August 28, 2026 | 12.69M |
| August 27, 2026 | 12.72M |
| August 26, 2026 | 12.62M |
| August 25, 2026 | 12.66M |
| August 24, 2026 | 12.37M |
| August 21, 2026 | 12.29M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AstraZeneca PLC | 2.950M |
| GSK Plc | 5.319M |
| Johnson & Johnson | 7.270M |
| Eli Lilly & Co. | 2.448M |
| Merck & Co., Inc. | 9.901M |